{"id":43184,"date":"2025-10-13T17:39:41","date_gmt":"2025-10-13T09:39:41","guid":{"rendered":"https:\/\/flcube.com\/?p=43184"},"modified":"2025-10-13T17:39:42","modified_gmt":"2025-10-13T09:39:42","slug":"sihuan-pharma-invests-in-swiss-aesthetic-tech-company-suisselle-secures-permanent-exclusive-distribution-of-cellbooster-in-china","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=43184","title":{"rendered":"Sihuan\u202fPharma Invests in Swiss Aesthetic Tech Company Suisselle, Secures Permanent Exclusive Distribution of CELLBOOSTER in China"},"content":{"rendered":"\n<p><strong>Sihuan Pharmaceutical Holdings Group Ltd.<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/quote\/0460:HKG\">HKG: 0460<\/a>) announced today that it has completed an equity investment in <strong>Suisselle SA<\/strong>, a Swiss\u2011based medical\u2011aesthetic company, and has signed a formal investment and subscription agreement. The deal will deepen the strategic partnership and position both companies to jointly capture the growing global medical\u2011aesthetic market.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-investment-highlights\">Investment Highlights<\/h3>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Investor<\/strong><\/td><td>Sihuan\u202fPharma (HKG:\u202f0460)<\/td><\/tr><tr><td><strong>Target<\/strong><\/td><td>Suisselle\u202fSA (Switzerland)<\/td><\/tr><tr><td><strong>Deal Structure<\/strong><\/td><td>Equity investment + subscription agreement<\/td><\/tr><tr><td><strong>Key Asset<\/strong><\/td><td><strong>CELLBOOSTER<\/strong> skin\u2011booster product line<\/td><\/tr><tr><td><strong>Post\u2011Deal Rights<\/strong><\/td><td>Permanent exclusive distribution of CELLBOOSTER in China for Sihuan\u202fPharma<\/td><\/tr><tr><td><strong>Strategic Rationale<\/strong><\/td><td>Leverage Suisselle\u2019s European platform to accelerate sales of Sihuan\u2011owned \u201cMeiyan Space\u201d products abroad<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-strategic-impact\">Strategic Impact<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Strengthened Supply Chain<\/strong> \u2013 Sihuan\u202fPharma will now own <strong>permanent exclusive distribution rights<\/strong> for CELLBOOSTER, solidifying its position as the sole Chinese distributor following its 2022 partnership.<\/li>\n\n\n\n<li><strong>Global Market Expansion<\/strong> \u2013 By tapping Suisselle\u2019s established European platform, the companies will jointly promote <strong>Meiyan Space<\/strong>\u2011developed products in Europe and other overseas markets.<\/li>\n\n\n\n<li><strong>Product Portfolio Diversification<\/strong> \u2013 The Group will continue to import and launch innovative aesthetic products from Suisselle and other European partners, enriching China\u2019s domestic aesthetic matrix.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-future-collaboration\">Future Collaboration<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Joint R&amp;D &amp; Marketing<\/strong> \u2013 Sihuan\u202fPharma will be deeply involved in the operation and development of CELLBOOSTER, driving localized innovation and marketing campaigns.<\/li>\n\n\n\n<li><strong>Platform Synergy<\/strong> \u2013 Suisselle\u2019s existing distribution network in Europe will serve as a launchpad for Sihuan\u2011owned products, while Sihuan\u2019s market expertise will help Suisselle penetrate the Chinese market.<\/li>\n\n\n\n<li><strong>Long\u2011Term Growth<\/strong> \u2013 The partnership aims to become a leading \u201cglobal\u2011to\u2011local\u201d model in the medical aesthetic industry, combining Swiss technology with Chinese market execution.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-about-sihuan-pharma\">About Sihuan\u202fPharma<\/h3>\n\n\n\n<p>Sihuan\u202fPharmaceutical Holdings Group Ltd. (HKEX:\u202f0460) is a China\u2011based biopharmaceutical company focusing on the discovery, development, and commercialization of innovative medical\u2011aesthetic and therapeutic products.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-about-suisselle\">About Suisselle<\/h3>\n\n\n\n<p>Suisselle SA is a Swiss medical\u2011aesthetic company specializing in advanced skin\u2011boosting technologies, including the CELLBOOSTER\u00ae platform.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Sihuan Pharmaceutical Holdings Group Ltd. (HKG: 0460) announced today that it has completed an equity&#8230;<\/p>\n","protected":false},"author":1,"featured_media":43185,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[930,100,146,4382],"class_list":["post-43184","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-hkg-0460","tag-medical-aesthetics","tag-sihuan-pharmaceutical","tag-suisselle-sa"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Sihuan\u202fPharma Invests in Swiss Aesthetic Tech Company Suisselle, Secures Permanent Exclusive Distribution of CELLBOOSTER in China - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Sihuan Pharmaceutical Holdings Group Ltd. (HKG: 0460) announced today that it has completed an equity investment in Suisselle SA, a Swiss\u2011based medical\u2011aesthetic company, and has signed a formal investment and subscription agreement. The deal will deepen the strategic partnership and position both companies to jointly capture the growing global medical\u2011aesthetic market.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=43184\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sihuan\u202fPharma Invests in Swiss Aesthetic Tech Company Suisselle, Secures Permanent Exclusive Distribution of CELLBOOSTER in China\" \/>\n<meta property=\"og:description\" content=\"Sihuan Pharmaceutical Holdings Group Ltd. (HKG: 0460) announced today that it has completed an equity investment in Suisselle SA, a Swiss\u2011based medical\u2011aesthetic company, and has signed a formal investment and subscription agreement. The deal will deepen the strategic partnership and position both companies to jointly capture the growing global medical\u2011aesthetic market.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=43184\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-13T09:39:41+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-13T09:39:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/1309.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43184#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43184\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Sihuan\u202fPharma Invests in Swiss Aesthetic Tech Company Suisselle, Secures Permanent Exclusive Distribution of CELLBOOSTER in China\",\"datePublished\":\"2025-10-13T09:39:41+00:00\",\"dateModified\":\"2025-10-13T09:39:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43184\"},\"wordCount\":339,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43184#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/1309.webp\",\"keywords\":[\"HKG: 0460\",\"Medical aesthetics\",\"Sihuan Pharmaceutical\",\"Suisselle SA\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=43184#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43184\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=43184\",\"name\":\"Sihuan\u202fPharma Invests in Swiss Aesthetic Tech Company Suisselle, Secures Permanent Exclusive Distribution of CELLBOOSTER in China - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43184#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43184#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/1309.webp\",\"datePublished\":\"2025-10-13T09:39:41+00:00\",\"dateModified\":\"2025-10-13T09:39:42+00:00\",\"description\":\"Sihuan Pharmaceutical Holdings Group Ltd. (HKG: 0460) announced today that it has completed an equity investment in Suisselle SA, a Swiss\u2011based medical\u2011aesthetic company, and has signed a formal investment and subscription agreement. The deal will deepen the strategic partnership and position both companies to jointly capture the growing global medical\u2011aesthetic market.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43184#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=43184\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43184#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/1309.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/1309.webp\",\"width\":1080,\"height\":608,\"caption\":\"Sihuan\u202fPharma Invests in Swiss Aesthetic Tech Company Suisselle, Secures Permanent Exclusive Distribution of CELLBOOSTER in China\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43184#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sihuan\u202fPharma Invests in Swiss Aesthetic Tech Company Suisselle, Secures Permanent Exclusive Distribution of CELLBOOSTER in China\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Sihuan\u202fPharma Invests in Swiss Aesthetic Tech Company Suisselle, Secures Permanent Exclusive Distribution of CELLBOOSTER in China - Insight, China&#039;s Pharmaceutical Industry","description":"Sihuan Pharmaceutical Holdings Group Ltd. (HKG: 0460) announced today that it has completed an equity investment in Suisselle SA, a Swiss\u2011based medical\u2011aesthetic company, and has signed a formal investment and subscription agreement. The deal will deepen the strategic partnership and position both companies to jointly capture the growing global medical\u2011aesthetic market.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=43184","og_locale":"en_US","og_type":"article","og_title":"Sihuan\u202fPharma Invests in Swiss Aesthetic Tech Company Suisselle, Secures Permanent Exclusive Distribution of CELLBOOSTER in China","og_description":"Sihuan Pharmaceutical Holdings Group Ltd. (HKG: 0460) announced today that it has completed an equity investment in Suisselle SA, a Swiss\u2011based medical\u2011aesthetic company, and has signed a formal investment and subscription agreement. The deal will deepen the strategic partnership and position both companies to jointly capture the growing global medical\u2011aesthetic market.","og_url":"https:\/\/flcube.com\/?p=43184","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-10-13T09:39:41+00:00","article_modified_time":"2025-10-13T09:39:42+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/1309.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=43184#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=43184"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Sihuan\u202fPharma Invests in Swiss Aesthetic Tech Company Suisselle, Secures Permanent Exclusive Distribution of CELLBOOSTER in China","datePublished":"2025-10-13T09:39:41+00:00","dateModified":"2025-10-13T09:39:42+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=43184"},"wordCount":339,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=43184#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/1309.webp","keywords":["HKG: 0460","Medical aesthetics","Sihuan Pharmaceutical","Suisselle SA"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=43184#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=43184","url":"https:\/\/flcube.com\/?p=43184","name":"Sihuan\u202fPharma Invests in Swiss Aesthetic Tech Company Suisselle, Secures Permanent Exclusive Distribution of CELLBOOSTER in China - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=43184#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=43184#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/1309.webp","datePublished":"2025-10-13T09:39:41+00:00","dateModified":"2025-10-13T09:39:42+00:00","description":"Sihuan Pharmaceutical Holdings Group Ltd. (HKG: 0460) announced today that it has completed an equity investment in Suisselle SA, a Swiss\u2011based medical\u2011aesthetic company, and has signed a formal investment and subscription agreement. The deal will deepen the strategic partnership and position both companies to jointly capture the growing global medical\u2011aesthetic market.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=43184#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=43184"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=43184#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/1309.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/1309.webp","width":1080,"height":608,"caption":"Sihuan\u202fPharma Invests in Swiss Aesthetic Tech Company Suisselle, Secures Permanent Exclusive Distribution of CELLBOOSTER in China"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=43184#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Sihuan\u202fPharma Invests in Swiss Aesthetic Tech Company Suisselle, Secures Permanent Exclusive Distribution of CELLBOOSTER in China"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/1309.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/43184","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=43184"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/43184\/revisions"}],"predecessor-version":[{"id":43187,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/43184\/revisions\/43187"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/43185"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=43184"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=43184"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=43184"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}